Biocon Ltd share price logo

Biocon Ltd

NSE: BIOCON

BSE: 532523

Mid Cap

Healthcare Sector

Pharma Sector

₹426.80

+8.20

(+1.96%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

Biocon Stock Performance

as on July 3, 2026 at 9:31 pm IST

  • Day's Low

    Day's High

    ₹418.60
    ₹428.80
    downward going graph

    1.92%

    Downside

    0.47%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    ₹331.00
    ₹440.40
    downward going graph

    22.45%

    Downside

    3.19%

    Upside

    downward going graph

Biocon share price movements today

Previous Close
₹418.60
Open
₹418.60
Volume
64.04L
Upper Circuit
₹459.90
Lower Circuit
₹376.30
Day's Low - High
₹418.60 - ₹428.80
52 Week Low - High
₹331.00 - ₹440.40

Biocon Historical Returns

1 Month Return
+ 2.58 %
3 Month Return
+ 20.23 %
1 Year Return
+ 12.3 %
3 Year Return
+ 62.56 %
5 Year Return
+ 5.8 %

Biocon Fundamentals

as on July 3, 2026 at 4:01 pm IST

Market Cap

₹69,555.35 Cr

Return on Equity (ROE)

0.4

PE Ratio (TTM)

152.97

Return on capital employed (ROCE)

2.07

Industry PE ratio

48.13

Beta (LTM)

0.74

P/B Ratio

3.55

Dividend Yield

0.15

PEG Ratio

-26.93

Quarterly Earnings Growth YOY

-56.77

EPS (TTM)

11.91

Book Value

180.27

Biocon Stock Valuation

as on July 3, 2026 at 4:01 pm IST

Biocon in the last 5 years

  • Overview

  • Trends

Lowest (24.48x)

March 19, 2024

Industry (48.13x)

July 3, 2026

Today (152.97x)

July 3, 2026

Highest (156.33x)

May 26, 2026

LowHigh

Today’s Price to Earnings Ratio: 152.97x

Biocon Technical Analysis

Track how Biocon technical analysis has moved over time to understand its trends.

1 day
1 week
1 month

Technicals Summary

Bearish

Neutral

Bullish

Bullish

Moving Averages

Bearish

Neutral

Bullish

Bullish

Oscillators

Bearish

Neutral

Bullish

Bearish

Overall

Bearish2
Bullish10
Neutral3

Oscillators

Name

Value

Action

MACD level (12,26)
3.46
Bullish
CCI (20)
140.78
Bearish
RSI (14)
62.65
Neutral
Momentum (10)
11.3
Bearish
ADI (14)
16.84
Neutral
Ultimate Oscillator (7,14,28)
45.21
Neutral

Moving Averages

Name

Value

Action

SMA (20)
417.7
Bullish
EMA (20)
418.6
Bullish
VWMA (20)
419.27
Bullish
SMA (50)
407.97
Bullish
EMA (50)
408.72
Bullish
SMA (200)
383.69
Bullish
EMA (200)
385.7
Bullish
KAMA (200)
409.71
Bullish
DEMA (200)
404.85
Bullish

Biocon Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Biocon with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Biocon Ltd image
Biocon Ltd
BUY69,555.351.16%0.781,42915,261
Divis Laboratories Ltd image
Divis Laboratories Ltd
HOLD1,79,377.129.64%0.502,1919,360
Torrent Pharmaceuticals Ltd image
Torrent Pharmaceuticals Ltd
BUY1,61,380.9444.9%0.872,13819,274
Gland Pharma Ltd image
Gland Pharma Ltd
BUY40,618.02-5.88%0.536985,616
Cipla Ltd image
Cipla Ltd
BUY1,17,800.009.92%0.523,86939,011
See all

Market expectation of Biocon Stock

Common consensus of the market based on various publicly available news, publications,brokerage expectation and market data

BUY

50.00%

Buy

18.75%

Hold

31.25%

Sell

Biocon Stock’s Investor Sentiment and Interest

Investment in Biocon Ltd Shares on INDmoney has dropped by -57.90% over the past 30 days, indicating reduced transactional activity.

Time period: to

Change:-57.90% versus previous 30 day period

Search interest for Biocon Ltd Stock has decreased by -39% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-39% versus previous 30 day period

Biocon Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Sales
3,392.6
3,548.7
3,863.8
3,376.1
3,545
3,773
4,358.1
3,910.1
4,262.5
4,123
4,484.3
Other Income
157.9
586.7
48.6
1,166.5
58.5
52.9
57.3
79.7
93
117.3
52.5
Total Income
3,620.2
4,540.4
3,965.7
4,599.4
3,648.9
3,874.3
4,474.3
4,021.6
4,388.5
4,290.3
4,569.1
Expenses
2,768.9
3,051
3,012.7
2,812.5
2,905
3,069.6
3,338.8
3,193
3,472
3,632.9
3,576.7
Operating Profit
623.7
497.7
851.1
563.6
640
703.4
1,019.3
717.1
790.5
490.1
907.6
Operating Profit Margin %
18.38%
14.02%
22.03%
16.69%
18.05%
18.64%
23.39%
18.34%
18.55%
11.89%
20.24%
Profit Before Interest, Tax and Depreciation
851.3
1,489.4
953
1,786.9
743.9
804.7
1,135.5
828.6
916.5
657.4
992.4
Interest
247.7
266.7
227
236
225.6
223.4
212.4
276.7
272.2
209.9
231.5
Depreciation
389.3
414.5
407
405.4
419.9
425.4
436.3
455
473
515.3
513.4
Profit Before Tax
214.3
808.2
319
1,145.5
98.4
155.9
486.8
96.9
171.3
-67.8
247.5
Tax Paid
41.6
54.9
96.1
283.7
71.3
74.8
27.4
7.7
38.5
-16
48.9
Profit After Tax
172.7
753.3
222.9
861.8
27.1
81.1
459.4
89.2
132.8
-51.8
198.6
Total Net profit including share of profit / Loss from associate company
172.7
753.3
222.9
861.8
27.1
81.1
459.4
89.2
132.8
-51.8
198.6
EPS
1.05
5.52
1.13
5.51
-0.13
0.21
2.88
0.26
0.66
1.08
0.79
Actual EPS
1.05
5.52
1.13
5.51
-0.13
0.21
2.88
0.26
0.66
1.08
0.79
Adjusted EPS
1.05
5.52
1.13
5.51
-0.13
0.21
2.88
0.26
0.66
1.08
0.79
Diluted EPS
1.05
5.51
1.13
5.51
-0.13
0.21
2.87
0.26
0.65
1.07
0.79

Biocon Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Sales
4,123.4
5,514.4
6,300.5
7,143.1
8,184
11,174.2
14,195.8
15,052.2
16,779.9
Other Income
227.5
339.9
228.9
267.1
212.7
375.9
865.5
1,304.7
342.5
Total Income
4,350.9
5,854.3
6,529.4
7,410.2
8,396.7
11,550.1
15,621.2
16,566.4
17,269.5
Expenses
3,294.3
4,120.7
4,726.3
5,569.7
6,531.8
9,120.9
11,552.8
12,095.4
13,874.6
Operating Profit
829.1
1,393.7
1,574.2
1,573.4
1,652.2
2,053.3
2,643
2,956.8
2,905.3
Operating Profit Margin %
20.11%
25.27%
24.99%
22.03%
20.19%
18.38%
18.62%
19.64%
17.31%
Profit Before Interest, Tax and Depreciation
1,056.6
1,733.6
1,803.1
1,840.5
1,864.9
2,429.2
4,068.4
4,471
3,394.9
Interest
61.5
70.9
64.9
57.7
67.6
419
974.4
897.4
990.3
Depreciation
385.1
447.8
552.2
715.1
814.2
1,113.1
1,568.8
1,687
1,956.7
Profit Before Tax
610
1,214.9
1,186
1,067.7
983.1
897.1
1,525.2
1,886.6
447.9
Tax Paid
156.9
212.3
315.1
221.5
211.5
254.1
227.4
457.2
79.1
Profit After Tax
453.1
1,002.6
870.9
846.2
771.6
643
1,297.8
1,429.4
368.8
Total Net profit including share of profit / Loss from associate company
453.1
1,002.6
870.9
846.2
771.6
643
1,297.8
1,429.4
368.8
EPS
6.31
15.3
6.32
6.24
5.44
3.88
8.55
8.46
2.82
Actual EPS
6.31
15.3
6.32
6.24
5.44
3.88
8.55
8.46
2.82
Adjusted EPS
3.16
7.65
6.32
6.24
5.44
3.88
8.55
8.46
2.82
Diluted EPS
6.27
15.2
6.3
6.19
5.42
3.87
8.54
8.46
2.82

Biocon Ltd Cash Flow

Figures in Rupees Crores

Mar 2016
Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Net Cash from Operating Activities
370.6
640
662.1
1,154.6
1,283.1
1,159.7
1,176.6
1,852.5
2,953.9
4,061.2
Cash Flow from Investing Activities
-1,138.2
-509.8
-683.6
-702.6
-1,505.3
-3,651.4
-1,662
-14,260.1
-1,001.6
-202.9
Cash Flow from Financing Activities
1,067.6
-177.5
-239.7
-241.7
387.6
2,564
242.1
13,048.7
-2,332.7
-1,854
Net Cash Flow
300
-47.3
-261.2
210.3
165.4
72.3
-243.3
641.1
-380.4
2,004.3

Biocon Stock Shareholding Pattern

Numbers in percentages

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Jan 2026
Mar 2026
Jun 2026
Promoters
60.64%
60.64%
60.64%
60.64%
60.64%
60.64%
60.64%
54.45%
54.45%
54.45%
44.91%
44.91%
44.68%
DII
14.08%
14.51%
13.68%
14.3%
14.44%
15.37%
15.72%
22.82%
22.1%
21.71%
24.16%
24.07%
21.92%
FII
7.96%
6.55%
5.63%
5.9%
5.93%
5.66%
5.66%
6.04%
6.61%
7.39%
7.14%
7.52%
0%
Public
16.92%
17.96%
19.73%
18.89%
18.75%
18.12%
17.76%
16.5%
16.69%
16.33%
23.69%
23.41%
23.74%
Total Outstanding Shares
1,20,06,00,000
1,20,06,00,000
1,20,06,00,000
1,20,06,00,000
1,20,06,00,000
1,20,06,00,000
1,20,06,00,000
1,33,69,63,635
1,33,69,63,635
1,33,69,63,635
1,62,09,07,773
1,62,09,07,773
1,62,96,94,135
Total Shareholders
4,15,046
4,34,339
4,70,261
4,43,513
4,39,503
4,27,705
4,24,297
4,28,131
4,13,191
3,94,279
3,94,759
3,86,593
3,92,509

Mutual Funds that own Biocon Stock

Check out the Mutual Funds with significant holdings in Biocon.

Biocon Corporate Actions

View detailed summary of the earnings and dividend history of Biocon.

  • Biocon Ltd Earnings Results

    Biocon Ltd’s net profit fell -63.45% since last year same period to ₹125.90Cr in the Q4 2025-2026. On a quarterly growth basis, Biocon Ltd has generated -12.45% fall in its net profits since last 3-months.

    Read More about Earnings Results

  • Biocon Ltd Dividends May,2026

    In the quarter ending March 2026, Biocon Ltd has declared dividend of ₹0.50 per share on 07 May 2026 - translating a dividend yield of 0.23%.

    Read More about Dividends

Indices Featuring Biocon Stock

Check stock indices that include Biocon.

Nifty Midcap 100

₹62,190.30

-117.60 (▲0.19%)

Nifty Midcap 150

₹22,884.35

-50.55 (▲0.22%)

Nifty 200

₹13,992.05

26.45 (▲0.19%)

Nifty LargeMidcap 250

₹16,643.80

5.35 (▲0.03%)

BSE 200

₹11,317.86

19.35 (▲0.17%)

BSE Healthcare

₹50,088.47

646.70 (▲1.31%)

Nifty MidSmallcap 400

₹21,111.00

-25.35 (▲0.12%)

S&P BSE 150 MidCap

₹16,778.28

-42.53 (▲0.25%)

S&P BSE 400 MidSmallCap

₹12,588.23

-17.06 (▲0.14%)

NIFTY PHARMA

₹25,745.15

436.25 (▲1.72%)

Nifty Healthcare

₹16,441.45

290.55 (▲1.80%)

S&P BSE 250 LargeMidCap

₹10,776.19

17.20 (▲0.16%)

BSE 500

₹36,431.45

55.43 (▲0.15%)

Nifty 500

₹23,301.15

36.35 (▲0.16%)

Insights on Biocon Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 4.29K Cr → 4.56K Cr (in ₹), with an average increase of 6.1% per quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 6 months, BIOCON stock has moved up by 7.0%

  • imgPOSITIVE IMPACT

    FII Holding Up

    img

    Foreign Institutions have increased holdings from 7.14% to 7.52% in Mar 2026 quarter

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 44.91% of holdings in Mar 2026 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Vimta Labs Ltd has given 184.6% return, outperforming this stock by 125.8%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Vimta Labs Ltd has given 23.5% return, outperforming this stock by 11.7%

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 23.69% to 23.41% in Mar 2026 quarter

  • imgNEGATIVE IMPACT

    MF Holding Down

    img

    Mutual Funds have decreased holdings from 17.03% to 16.53% in Mar 2026 quarter

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, 143.8 Cr → 125.9 Cr (in ₹), with an average decrease of 12.5% per quarter

Biocon Stock Futures & Options Contracts

View the latest movement in Biocon Futures & Options, including strike prices, expiry dates, and percentage changes.

Biocon Options

Name
Expiry
Strike Price
LTP
Absolute Change
Change
BIOCON 28 Jul ₹430 Call
July 28, 2026
₹430
₹12.05
3.95
48.77%
BIOCON 28 Jul ₹420 Call
July 28, 2026
₹420
₹17.9
5.35
42.63%
BIOCON 28 Jul ₹450 Call
July 28, 2026
₹450
₹4.8
1.75
57.38%
BIOCON 28 Jul ₹425 Call
July 28, 2026
₹425
₹14.9
4.75
46.8%

Biocon Futures

Name
Expiry
Strike Price
LTP
Absolute Change
Change
BIOCON 28 Jul Fut
July 28, 2026
-
₹430.4
9.35
2.22%
BIOCON 25 Aug Fut
August 25, 2026
-
₹432.5
9.6
2.27%
BIOCON 29 Sep Fut
September 29, 2026
-
₹434.25
7.76
1.82%

About Biocon Ltd

Biocon Ltd is a biopharmaceutical company founded in 1978 by Kiran Mazumdar-Shaw. It is headquartered in Bangalore, India and is one of the top biopharma companies in the world. The company operates in four core areas - biopharmaceuticals, biologics, research services, and clinical research. Biocon's biopharmaceuticals business focuses on biologics and biosimilars, while its biologics business focuses on the discovery, development and commercialization of novel biologics. Its research services include contract research and manufacturing services, while its clinical research business focuses on clinical trials and clinical data management.

Biocon's top products include insulin, monoclonal antibodies, enzymes, and vaccines. Its popular brands include Insugen, Insupen, and Insugen Plus. The company has a strong presence in the Indian market and is expanding its reach to other countries. Biocon has also established its presence in the US, Europe, and Japan.

Revenue: ₹4,484.30Cr as on March 2026 (Q4 FY26)
Net Profit: ₹198.60Cr as on March 2026 (Q4 FY26)
Listing date: 07 Apr, 2004
Chairperson Name: Kiran Mazumdar Shaw
OrganisationBiocon Ltd
HeadquartersBangalore
IndustryPharmaceuticals
CEOKiran Mazumdar Shaw
E-voting on sharesClick here to vote

FAQs

What is Biocon share price today?

Biocon share price today stands at ₹426.8 as on at the close of the market. Biocon share today touched a day high of ₹428.8 and a low of ₹418.6.

What is the 52 week high and 52 week low range for Biocon share?

Biocon touched a 52 week high of ₹440.4 and a 52 week low of ₹331. Biocon share price today i.e. is closed at ₹426.8, which is -3.09% down from its 52 week high and 28.94% up from its 52 week low.

What is Biocon's market capitalisation today?

Biocon market capitalisation is ₹69,555.35 Cr as on .

How to buy Biocon shares?

To buy Biocon shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for BIOCON or Biocon Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Biocon shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Biocon trading volume today?

Biocon trading volume is 64.04L as on . This means that 64.04L shares of Biocon were bought and sold on the stock market during today's trading session.